-
1
-
-
78650546347
-
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
-
Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 (Suppl. 1): i5-i14.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. i5-i14
-
-
Pagano, L.1
Akova, M.2
Dimopoulos, G.3
Herbrecht, R.4
Drgona, L.5
Blijlevens, N.6
-
2
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
-
(2002)
N Engl J Med
, vol.347
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
-
3
-
-
53349171951
-
Factors associated with overall and attributable mortality in invasive aspergillosis
-
Nivoix Y, Velten M, Letscher-Bru V et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47: 1176-1184.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1176-1184
-
-
Nivoix, Y.1
Velten, M.2
Letscher-Bru, V.3
-
4
-
-
34848928703
-
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
-
Pappas PG, Rotstein CM, Betts RF et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007; 45: 883-893.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 883-893
-
-
Pappas, P.G.1
Rotstein, C.M.2
Betts, R.F.3
-
5
-
-
34247564562
-
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
-
Kuse ER, Chetchotisakd P, da Cunha CA et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369: 1519-1527.
-
(2007)
Lancet
, vol.369
, pp. 1519-1527
-
-
Kuse, E.R.1
Chetchotisakd, P.2
da Cunha, C.A.3
-
6
-
-
79551617211
-
Impact of invasive fungal infection on the chemotherapy schedule and event-free survival in acute leukemia patients who survive to invasive fungal infection: a case- control study
-
Even C, Bastuji-Garin S, Hicheri Y et al. Impact of invasive fungal infection on the chemotherapy schedule and event-free survival in acute leukemia patients who survive to invasive fungal infection: a case- control study. Haematologica 2011; 96: 337-341.
-
(2011)
Haematologica
, vol.96
, pp. 337-341
-
-
Even, C.1
Bastuji-Garin, S.2
Hicheri, Y.3
-
7
-
-
0024371959
-
Empiric antifungal therapy in febrile granulocytopenic patients
-
EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-672.
-
(1989)
Am J Med
, vol.86
, pp. 668-672
-
-
-
8
-
-
0019946004
-
Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
-
Pizzo P, Robichaud KJ, Gill FA, Witebsky FG. Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101-111.
-
(1982)
Am J Med
, vol.72
, pp. 101-111
-
-
Pizzo, P.1
Robichaud, K.J.2
Gill, F.A.3
Witebsky, F.G.4
-
9
-
-
33745792967
-
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
-
Chamilos G, Luna M, Lewis R et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-989.
-
(2006)
Haematologica
, vol.91
, pp. 986-989
-
-
Chamilos, G.1
Luna, M.2
Lewis, R.3
-
10
-
-
84886306657
-
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study
-
Lewis R, Cahyame-Zuniga L, Leventakos K et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 2013; 56: 638-645.
-
(2013)
Mycoses
, vol.56
, pp. 638-645
-
-
Lewis, R.1
Cahyame-Zuniga, L.2
Leventakos, K.3
-
11
-
-
0036532203
-
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
-
Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 909-917
-
-
Marr, K.A.1
Carter, R.A.2
Crippa, F.3
Wald, A.4
Corey, L.5
-
12
-
-
77950682818
-
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study
-
Pagano L, Caira M, Candoni A et al. Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica 2010; 22: 644-650.
-
(2010)
Haematologica
, vol.22
, pp. 644-650
-
-
Pagano, L.1
Caira, M.2
Candoni, A.3
-
13
-
-
0013877409
-
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
-
Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
-
(1966)
Ann Intern Med
, vol.64
, pp. 328-340
-
-
Bodey, G.P.1
Buckley, M.2
Sathe, Y.S.3
Freireich, E.J.4
-
14
-
-
0842307151
-
Empirical antifungal therapy
-
Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents 2004; 23: 105-112.
-
(2004)
Int J Antimicrob Agents
, vol.23
, pp. 105-112
-
-
Klastersky, J.1
-
15
-
-
34547546151
-
Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
-
Marchetti O, Cordonnier C, Calandra T. Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer 2007; S5: 32-42.
-
(2007)
Eur J Cancer
, vol.S5
, pp. 32-42
-
-
Marchetti, O.1
Cordonnier, C.2
Calandra, T.3
-
16
-
-
48749096676
-
Delaying amphotericin-B based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
-
Chamilos G, Lewis R, Kontoyiannis D. Delaying amphotericin-B based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-509.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 503-509
-
-
Chamilos, G.1
Lewis, R.2
Kontoyiannis, D.3
-
17
-
-
0028827035
-
Pulmonary aspergillosis: early diagnosis improves survival
-
von EiffEM, Roos N, Schulten R et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341-347.
-
(1995)
Respiration
, vol.62
, pp. 341-347
-
-
von Eiff, E.M.1
Roos, N.2
Schulten, R.3
-
18
-
-
0033545538
-
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
-
Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340: 764-771.
-
(1999)
N Engl J Med
, vol.340
, pp. 764-771
-
-
Walsh, T.J.1
Finberg, R.W.2
Arndt, C.3
-
19
-
-
0037165259
-
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
-
Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-234.
-
(2002)
N Engl J Med
, vol.346
, pp. 225-234
-
-
Walsh, T.J.1
Pappas, P.2
Winston, D.J.3
-
20
-
-
4644346490
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
-
Walsh TJ, Teppler H, Donowitz GR et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
-
(2004)
N Engl J Med
, vol.351
, pp. 1391-1402
-
-
Walsh, T.J.1
Teppler, H.2
Donowitz, G.R.3
-
21
-
-
9844239388
-
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
-
Prentice H, Hann I, Herbrecht R et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 1997; 98: 711-718.
-
(1997)
Br J Haematol
, vol.98
, pp. 711-718
-
-
Prentice, H.1
Hann, I.2
Herbrecht, R.3
-
23
-
-
0034456963
-
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
-
Wingard JR, White MH, Anaissie E, Raffali J, Goodman J, Arrieta A. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31: 1155-1163.
-
(2000)
Clin Infect Dis
, vol.31
, pp. 1155-1163
-
-
Wingard, J.R.1
White, M.H.2
Anaissie, E.3
Raffali, J.4
Goodman, J.5
Arrieta, A.6
-
24
-
-
79951816939
-
Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America
-
Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52: e56-e93.
-
(2011)
Clin Infect Dis
, vol.52
, pp. e56-e93
-
-
Freifeld, A.G.1
Bow, E.J.2
Sepkowitz, K.A.3
-
25
-
-
84865422021
-
Azole preexposure affects the Aspergillus fumigatus population in patients
-
Alanio A, Cabaret O, Sitterle E et al. Azole preexposure affects the Aspergillus fumigatus population in patients. Antimicrob Agents Chemother 2012; 56: 4948-4950.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 4948-4950
-
-
Alanio, A.1
Cabaret, O.2
Sitterle, E.3
-
26
-
-
80755182326
-
Azole resistance in Aspergillus fumigatus-current epidemiology and future perspectives
-
Alanio A, Cordonnier C, Bretagne S. Azole resistance in Aspergillus fumigatus-current epidemiology and future perspectives. Current Fungal Infect Rep 2011; 5: 168-178.
-
(2011)
Current Fungal Infect Rep
, vol.5
, pp. 168-178
-
-
Alanio, A.1
Cordonnier, C.2
Bretagne, S.3
-
27
-
-
0029800728
-
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
-
Boeckh M, Gooley T, Myerson D, Cunningham T, Schoch G, Bowden R. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063-4071.
-
(1996)
Blood
, vol.88
, pp. 4063-4071
-
-
Boeckh, M.1
Gooley, T.2
Myerson, D.3
Cunningham, T.4
Schoch, G.5
Bowden, R.6
-
28
-
-
51049108165
-
Management of CMV, HHV6, HHV7 and Kaposi-sarcoma herpesvirus infections in patients with hematological malignancies including stem cell transplantation
-
Ljungman P, De La Camara R, Cordonnier C et al. Management of CMV, HHV6, HHV7 and Kaposi-sarcoma herpesvirus infections in patients with hematological malignancies including stem cell transplantation. Bone Marrow Transplant 2008; 42: 227-240.
-
(2008)
Bone Marrow Transplant
, vol.42
, pp. 227-240
-
-
Ljungman, P.1
De La Camara, R.2
Cordonnier, C.3
-
29
-
-
0037090071
-
Definitions of cytomegalovirus infection and disease in transplant recipients
-
Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1094-1097
-
-
Ljungman, P.1
Griffiths, P.2
Paya, C.3
-
30
-
-
78650210760
-
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
-
Blenow O, Remberger M, Klingspor L et al. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1710-1718.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 1710-1718
-
-
Blenow, O.1
Remberger, M.2
Klingspor, L.3
-
31
-
-
63649156819
-
Empirical versus pre-emptive antifungal strategy in high-risk febrile neutropenic patients: a prospective randomized study
-
Cordonnier C, Pautas C, Maury S et al. Empirical versus pre-emptive antifungal strategy in high-risk febrile neutropenic patients: a prospective randomized study. Clin Infect Dis 2009; 48: 1042-1051.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1042-1051
-
-
Cordonnier, C.1
Pautas, C.2
Maury, S.3
-
32
-
-
64949149897
-
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after Allo-SCT
-
Hebart H, Klingspor L, Klingebiel T et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after Allo-SCT. Bone Marrow Transplant 2009; 43: 553-561.
-
(2009)
Bone Marrow Transplant
, vol.43
, pp. 553-561
-
-
Hebart, H.1
Klingspor, L.2
Klingebiel, T.3
-
33
-
-
84878465978
-
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk hematology patients: a randomised controlled trial
-
Morrissey O, Chen S, Sorrell T et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk hematology patients: a randomised controlled trial. Lancet Infect Dis 2013; 13: 519-528.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 519-528
-
-
Morrissey, O.1
Chen, S.2
Sorrell, T.3
-
35
-
-
26444584546
-
Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies
-
Weisser M, Rausch C, Simcock M et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005; 41: 1143-1149.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1143-1149
-
-
Weisser, M.1
Rausch, C.2
Simcock, M.3
-
36
-
-
77950511957
-
Aspergillus PCR: one step closer towards standardisation
-
White P, Bretagne S, Klingspor L et al. Aspergillus PCR: one step closer towards standardisation. J Clin Microbiol 2010; 48: 1231-1240.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 1231-1240
-
-
White, P.1
Bretagne, S.2
Klingspor, L.3
-
37
-
-
0021350050
-
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
-
Gerson S, Talbot G, Hurwitz S, Strom B, Lusk E, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-351.
-
(1984)
Ann Intern Med
, vol.100
, pp. 345-351
-
-
Gerson, S.1
Talbot, G.2
Hurwitz, S.3
Strom, B.4
Lusk, E.5
Cassileth, P.A.6
-
38
-
-
17144403463
-
Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies
-
Muhlemann K, Wenger C, Zenhausern R, Tauber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 2005; 19: 545-550.
-
(2005)
Leukemia
, vol.19
, pp. 545-550
-
-
Muhlemann, K.1
Wenger, C.2
Zenhausern, R.3
Tauber, M.G.4
-
39
-
-
84886634582
-
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model
-
Schwarzinger M, Sagaon-Teyssier S, Cabaret O, Bretagne S, Cordonnier C. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model. PlosOne 2013; 8: e65776.
-
(2013)
PlosOne
, vol.8
, pp. e65776
-
-
Schwarzinger, M.1
Sagaon-Teyssier, S.2
Cabaret, O.3
Bretagne, S.4
Cordonnier, C.5
-
40
-
-
27444434378
-
Between over- and undertreatment of invasive fungal disease
-
De Pauw BE. Between over- and undertreatment of invasive fungal disease. Clin Infect Dis 2005; 41: 1251-1253.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1251-1253
-
-
De Pauw, B.E.1
-
41
-
-
27444447144
-
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study
-
Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1242-1250
-
-
Maertens, J.1
Theunissen, K.2
Verhoef, G.3
-
42
-
-
67651174360
-
An early CT-diagnosis based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality
-
Dignan FL, Evans SO, Ethell ME et al. An early CT-diagnosis based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplant 2009; 44: 51-56.
-
(2009)
Bone Marrow Transplant
, vol.44
, pp. 51-56
-
-
Dignan, F.L.1
Evans, S.O.2
Ethell, M.E.3
-
43
-
-
80052355809
-
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-chart project
-
Pagano L, Caira M, Nosari A et al. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-chart project. Haematologica 2011; 96: 1366-1370.
-
(2011)
Haematologica
, vol.96
, pp. 1366-1370
-
-
Pagano, L.1
Caira, M.2
Nosari, A.3
-
44
-
-
75149154262
-
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
-
Aguilar-Guisado M, Espigado I, Cordero E et al. Empirical antifungal therapy in selected patients with persistent febrile neutropenia. Bone Marrow Transplant 2010; 45: 159-164.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 159-164
-
-
Aguilar-Guisado, M.1
Espigado, I.2
Cordero, E.3
-
45
-
-
77449124531
-
Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study
-
Girmenia C, Micozzi A, Gentile G et al. Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study. J Clin Oncol 2010; 28: 667-674.
-
(2010)
J Clin Oncol
, vol.28
, pp. 667-674
-
-
Girmenia, C.1
Micozzi, A.2
Gentile, G.3
-
46
-
-
58349122651
-
Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
-
Barnes RA, White PL, Bygrave C, Evans N, Healy B, Kell J. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J Clin Pathol 2009; 62: 64-69.
-
(2009)
J Clin Pathol
, vol.62
, pp. 64-69
-
-
Barnes, R.A.1
White, P.L.2
Bygrave, C.3
Evans, N.4
Healy, B.5
Kell, J.6
-
47
-
-
0030978298
-
Early detection and identification of Candida and Aspergillus species in blood using molecular probes
-
Einsele H, Hebart H, Roller G et al. Early detection and identification of Candida and Aspergillus species in blood using molecular probes. J Clin Microbiol 1997; 35: 1353-1360.
-
(1997)
J Clin Microbiol
, vol.35
, pp. 1353-1360
-
-
Einsele, H.1
Hebart, H.2
Roller, G.3
-
48
-
-
33746419137
-
Detection of PCR-amplified fungal DNA by using a PCR-ELISA system
-
Loeffler J, Hebart H, Sepe S, Schumacher U, Klingebiel T, Einsele H. Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med Mycol 1998; 36: 275-279.
-
(1998)
Med Mycol
, vol.36
, pp. 275-279
-
-
Loeffler, J.1
Hebart, H.2
Sepe, S.3
Schumacher, U.4
Klingebiel, T.5
Einsele, H.6
-
49
-
-
84965190913
-
Galactomannan detection for invasive aspergillosis in immunocompromized patients
-
Leeflang M, Debets-Ossenkopp Y, Visser C et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008; 8: CD007394.
-
(2008)
Cochrane Database Syst Rev
, vol.8
, pp. CD007394
-
-
Leeflang, M.1
Debets-Ossenkopp, Y.2
Visser, C.3
-
50
-
-
0035869539
-
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
-
Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
-
(2001)
Blood
, vol.97
, pp. 1604-1610
-
-
Maertens, J.1
Verhaegen, J.2
Lagrou, K.3
Van Eldere, J.4
Boogaerts, M.5
-
51
-
-
33646464211
-
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis
-
Pfeiffer C, Fine J, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417-1427.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1417-1427
-
-
Pfeiffer, C.1
Fine, J.2
Safdar, N.3
-
52
-
-
77957765288
-
Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens
-
White P, Perry M, Loeffler J et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 2010; 48: 3753-3755.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 3753-3755
-
-
White, P.1
Perry, M.2
Loeffler, J.3
-
53
-
-
0032856762
-
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis
-
Maertens J, Verhaegen J, Demuynck H et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
-
(1999)
J Clin Microbiol
, vol.37
, pp. 3223-3228
-
-
Maertens, J.1
Verhaegen, J.2
Demuynck, H.3
-
54
-
-
58549118484
-
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
-
Mengoli C, Cruciani M, Barnes R, Loeffler J, Donnelly J. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89-96.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 89-96
-
-
Mengoli, C.1
Cruciani, M.2
Barnes, R.3
Loeffler, J.4
Donnelly, J.5
-
55
-
-
84862219718
-
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
-
Marchetti O, Lamoth F, Mikulska M, Viscoli CV, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-854.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 846-854
-
-
Marchetti, O.1
Lamoth, F.2
Mikulska, M.3
Viscoli, C.V.4
Verweij, P.5
Bretagne, S.6
-
56
-
-
79953766802
-
b-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis
-
Karageorgopoulos D, Vouloumanou E, Ntziora F, Micahlopoulos A, Rafailidis P, Falagas M. b-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52: 750-770.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 750-770
-
-
Karageorgopoulos, D.1
Vouloumanou, E.2
Ntziora, F.3
Micahlopoulos, A.4
Rafailidis, P.5
Falagas, M.6
-
57
-
-
84856908797
-
b-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL3)
-
Lamoth F, Cruciani M, Mengoli C et al. b-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL3). Clin Infect Dis 2012; 54: 633-643.
-
(2012)
Clin Infect Dis
, vol.54
, pp. 633-643
-
-
Lamoth, F.1
Cruciani, M.2
Mengoli, C.3
-
58
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group
-
De Pauw B, Walsh T, Donnelly JP et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-1821.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1813-1821
-
-
De Pauw, B.1
Walsh, T.2
Donnelly, J.P.3
-
59
-
-
20444371963
-
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay
-
Marr K, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-1769.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1762-1769
-
-
Marr, K.1
Laverdiere, M.2
Gugel, A.3
Leisenring, W.4
-
60
-
-
68949108384
-
Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophilcurve
-
Portugal R, Garinca M, Nucci M. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophilcurve. J Clin Oncol 2009; 27: 3849-3854.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3849-3854
-
-
Portugal, R.1
Garinca, M.2
Nucci, M.3
|